MDGEF fundamentals
An in-depth look to MediGene AG operating, investing, and financing activities
MDGEF free cash flow for H2 23 is -8.17 M USD. For 2023, MDGEF free cash flow was -17.42 M USD and operating cash flow was -16.69 M USD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
TTM